In vivo CRISPR screen identifies gene edits that strengthen CAR-T therapy against solid tumors. For patients with blood cancers like leukemia and lymphoma, the immunotherapy known as CAR-T cell therapy can be lifesaving.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: For patients with blood cancers like leukemia and lymphoma, the immunotherapy known as CAR-T cell therapy can be lifesaving. Doctors remove a patient's immune cells, called T cells, engineer them in the lab to better recognize and attack cancer, and infuse them back into the bloodstream.
- Ponto de atenção: vivo.
- Ponto de atenção: crispr.
- Ponto de atenção: screen.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.
